Filters
reset allOther countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Centogene AG - the Rare Disease Company Germany | 243 | 238 |
|
DHH - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Invitae Disorders of Sex Development Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 88 | 53 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
PreventionGenetics, part of Exact Sciences United States | 128 | 85 |
|
Differences of Sex Development (DSD) Panel PreventionGenetics, part of Exact Sciences United States | 149 | 158 |
|
Differences of Sex Development (DSD) and Infertility Panel PreventionGenetics, part of Exact Sciences United States | 223 | 238 |
|
PreventionGenetics, part of Exact Sciences United States | 128 | 139 |
|
PreventionGenetics, part of Exact Sciences United States | 96 | 105 |
|
DHH-related Differences of Sex Development via the DHH Gene PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
Genital Abnormalities / Sex Development Disorders Panel Genologica Medica Spain | 95 | 49 |
|
Custom XomeDx Slice – Differences of Sex Development (Proband Only) GeneDx United States | 21 | 112 |
|
46,XY sex reversal: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 11 | 10 |
|
Fulgent Genetics United States | 16 | 9 |
|
Fulgent Genetics United States | 92 | 56 |
|
Fulgent Genetics United States | 76 | 41 |
|
Nonsyndromic Disorders of Testicular Development: gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 2 | 4 |
|
Abnormal/Ambiguous Genitalia Panel Genetic Services Laboratory University of Chicago United States | 81 | 92 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.